title: Can fenretinide protect women against ovarian cancer?
authors.forename: G
authors.initials: G
authors.lastname: De Palo
authors.forename: U
authors.initials: U
authors.lastname: Veronesi
authors.forename: T
authors.initials: T
authors.lastname: Camerini
authors.forename: F
authors.initials: F
authors.lastname: Formelli
authors.forename: G
authors.initials: G
authors.lastname: Mascotti
authors.forename: C
authors.initials: C
authors.lastname: Boni
authors.forename: V
authors.initials: V
authors.lastname: Fosser
authors.forename: M
authors.initials: M
authors.lastname: Del Vecchio
authors.forename: T
authors.initials: T
authors.lastname: Campa
authors.forename: A
authors.initials: A
authors.lastname: Costa
mesh_terms: D005260:Female; D017313:Fenretinide / Q000627:therapeutic use*; D006801:Humans; D010051:Ovarian Neoplasms / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D017313:Fenretinide